Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children

Objectives Severe obesity (SO) prevalence varies between reference curve-based definitions (WHO: ≥99th percentile, Centers for Disease Control and Prevention (CDC): >1.2×95th percentile). Whether SO definitions differentially predict cardiometabolic disease risk is critical for proper clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Gilles Paradis, Melanie Henderson, Lisa Kakinami, Angelo Tremblay, Anna Smyrnova
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e058857.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574370840576000
author Gilles Paradis
Melanie Henderson
Lisa Kakinami
Angelo Tremblay
Anna Smyrnova
author_facet Gilles Paradis
Melanie Henderson
Lisa Kakinami
Angelo Tremblay
Anna Smyrnova
author_sort Gilles Paradis
collection DOAJ
description Objectives Severe obesity (SO) prevalence varies between reference curve-based definitions (WHO: ≥99th percentile, Centers for Disease Control and Prevention (CDC): >1.2×95th percentile). Whether SO definitions differentially predict cardiometabolic disease risk is critical for proper clinical care and management but is unknown.Design Prospective cohort studySetting SO definitions were applied at baseline (2005–2008, Mage=9.6 years, n=548), and outcomes (fasting lipids, glucose, homoeostatic model assessment (HOMA-IR) and blood pressure) were assessed at first follow-up (F1: 2008–2011, Mage=11.6 years) and second follow-up (2015–2017, Mage=16.8 years) of the Quebec Adipose and Lifestyle Investigation in Youth cohort in Montreal, Quebec.Participants Respondents were youth who had at least one biological parent with obesity.Primary outcome measures Unfavourable cardiometabolic levels of fasting blood glucose (≥6.1 mmol/L), insulin resistance (HOMA-IR index ≥2.0), high-density lipoprotein <1.03 mmol/L, low-density lipoprotein ≥2.6 mmol/L and triglycerides >1.24 mmol/L. Unfavourable blood pressure was defined as ≥90th percentile for age-adjusted, sex-adjusted and height-adjusted systolic or diastolic blood pressure.Analysis Area under the receiver operating characteristic curve (AUC) and McFadden psuedo R2 for predicting F1 or F2 unfavourable cardiometabolic levels from baseline SO definitions were calculated. Agreement was assessed with kappas.Results Baseline SO prevalence differed (WHO: 18%, CDC: 6.7%). AUCs ranged from 0.52 to 0.77, with fair agreement (kappa=37%–55%). WHO-SO AUCs for detecting unfavourable HOMA-IR (AUC>0.67) and high-density lipoprotein (AUC>0.59) at F1 were statistically superior than CDC-SO (AUC>0.59 and 0.53, respectively; p<0.05). Only HOMA-IR and the presence of more than three risk factors had acceptable model fit. WHO-SO was not more predictive than WHO-obesity, but CDC-SO was statistically inferior to CDC-obesity.Conclusion WHO-SO is statistically superior at predicting cardiometabolic risk than CDC-SO. However, as most AUCs were generally uninformative, and obesity definitions were the same if not better than SO, the improvement may not be clinically meaningful.
format Article
id doaj-art-6038f3d6fb24465b8f23c26b6f50029c
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-6038f3d6fb24465b8f23c26b6f50029c2025-02-01T14:35:09ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-058857Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of childrenGilles Paradis0Melanie Henderson1Lisa Kakinami2Angelo Tremblay3Anna Smyrnova4Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, CanadaDepartment of Pediatrics, Université de Montréal, Montreal, QC, CanadaPERFORM Centre, Concordia University, Montreal, Québec, CanadaDépartement de kinésiologie, Université Laval, Quebec City, Quebec, CanadaDepartment of Mathematics and Statistics, Concordia University, Montreal, Québec, CanadaObjectives Severe obesity (SO) prevalence varies between reference curve-based definitions (WHO: ≥99th percentile, Centers for Disease Control and Prevention (CDC): >1.2×95th percentile). Whether SO definitions differentially predict cardiometabolic disease risk is critical for proper clinical care and management but is unknown.Design Prospective cohort studySetting SO definitions were applied at baseline (2005–2008, Mage=9.6 years, n=548), and outcomes (fasting lipids, glucose, homoeostatic model assessment (HOMA-IR) and blood pressure) were assessed at first follow-up (F1: 2008–2011, Mage=11.6 years) and second follow-up (2015–2017, Mage=16.8 years) of the Quebec Adipose and Lifestyle Investigation in Youth cohort in Montreal, Quebec.Participants Respondents were youth who had at least one biological parent with obesity.Primary outcome measures Unfavourable cardiometabolic levels of fasting blood glucose (≥6.1 mmol/L), insulin resistance (HOMA-IR index ≥2.0), high-density lipoprotein <1.03 mmol/L, low-density lipoprotein ≥2.6 mmol/L and triglycerides >1.24 mmol/L. Unfavourable blood pressure was defined as ≥90th percentile for age-adjusted, sex-adjusted and height-adjusted systolic or diastolic blood pressure.Analysis Area under the receiver operating characteristic curve (AUC) and McFadden psuedo R2 for predicting F1 or F2 unfavourable cardiometabolic levels from baseline SO definitions were calculated. Agreement was assessed with kappas.Results Baseline SO prevalence differed (WHO: 18%, CDC: 6.7%). AUCs ranged from 0.52 to 0.77, with fair agreement (kappa=37%–55%). WHO-SO AUCs for detecting unfavourable HOMA-IR (AUC>0.67) and high-density lipoprotein (AUC>0.59) at F1 were statistically superior than CDC-SO (AUC>0.59 and 0.53, respectively; p<0.05). Only HOMA-IR and the presence of more than three risk factors had acceptable model fit. WHO-SO was not more predictive than WHO-obesity, but CDC-SO was statistically inferior to CDC-obesity.Conclusion WHO-SO is statistically superior at predicting cardiometabolic risk than CDC-SO. However, as most AUCs were generally uninformative, and obesity definitions were the same if not better than SO, the improvement may not be clinically meaningful.https://bmjopen.bmj.com/content/12/6/e058857.full
spellingShingle Gilles Paradis
Melanie Henderson
Lisa Kakinami
Angelo Tremblay
Anna Smyrnova
Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
BMJ Open
title Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
title_full Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
title_fullStr Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
title_full_unstemmed Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
title_short Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
title_sort comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children
url https://bmjopen.bmj.com/content/12/6/e058857.full
work_keys_str_mv AT gillesparadis comparisonofdifferentsevereobesitydefinitionsinpredictingfuturecardiometabolicriskinalongitudinalcohortofchildren
AT melaniehenderson comparisonofdifferentsevereobesitydefinitionsinpredictingfuturecardiometabolicriskinalongitudinalcohortofchildren
AT lisakakinami comparisonofdifferentsevereobesitydefinitionsinpredictingfuturecardiometabolicriskinalongitudinalcohortofchildren
AT angelotremblay comparisonofdifferentsevereobesitydefinitionsinpredictingfuturecardiometabolicriskinalongitudinalcohortofchildren
AT annasmyrnova comparisonofdifferentsevereobesitydefinitionsinpredictingfuturecardiometabolicriskinalongitudinalcohortofchildren